Date published: 2025-12-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

SIRT2 Inhibitor, Inactive Control (CAS 304896-21-7)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
AGK7
Application:
CAS Number:
304896-21-7
Purity:
≥97%
Molecular Weight:
434.3
Molecular Formula:
C23H13Cl2N3O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

SIRT2 Inhibitor, Inactive Control, also known as AGK7, is a cell-permeable structural isomer of SIRT2 (sirtuin 2) Inhibitor, AGK2 (sc-202813) that selectively inhibits SIRT3 over SIRT1 and SIRT2 (IC50 = >5 muM, >50 muM and >50 muM for SIRT3, SIRT1 and SIRT2, respectively). SIRT2 Inhibitor, Inactive Control poorly affects both alpha-synuclein-mediated toxicity and alpha-Syn aggregation in alpha-Syn-H4 cells. It is also an inhibitor of SIRT1 (sirtuin 1) and SIRT3 (sirtuin 3). In catalysis, it exhibits high activity and selectivity in various reactions such as oxidation, reduction, and cross-coupling reactions. In gas storage, the compound has a high adsorption capacity for gases such as hydrogen, methane, and carbon dioxide.


SIRT2 Inhibitor, Inactive Control (CAS 304896-21-7) References

  1. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.  |  Outeiro, TF., et al. 2007. Science. 317: 516-9. PMID: 17588900

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

SIRT2 Inhibitor, Inactive Control, 5 mg

sc-204281
5 mg
$255.00

What is the recommended dosage of this product for use in human cells in vitro?

Asked by: ChemSynth123
Thank you for your question. SIRT2 Inhibitor, Inactive Control, AGK7 (CAS 304896-21-7): sc-204281 was used in a concentration of 10µM in the paper listed under References on the Description tab. Please note, AGK7 was used on human H4 cells while testing α-Syn-mediated toxicity.
Answered by: Chemical Support 7
Date published: 2017-03-02
  • y_2025, m_11, d_14, h_6CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_204281, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 174ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from OuteiroOuteiro, TF. et al. (PubMed 17588900) reported that inhibition of SIRT2 via AGK7 rescued alpha-synuclein-mediated toxicity in models of Parkinson's disease. Furthermore, the inhibitor protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease. -SCBT Publication Review
Date published: 2015-05-25
  • y_2025, m_11, d_14, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204281, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 14ms
  • REVIEWS, PRODUCT
SIRT2 Inhibitor, Inactive Control is rated 5.0 out of 5 by 1.
  • y_2025, m_11, d_14, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204281, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 95ms
  • REVIEWS, PRODUCT